Skip to main content
. 2020 Dec 3;11:544754. doi: 10.3389/fphar.2020.544754

TABLE 6.

The subgroup analysis results of all grade CRS and severe CRS.

Subgroup No of trails CRS (95% CI) p for differences CRS≥3 (95% CI) p for differences
Conditions
 CP 3 0.8625 [0.7690; 0.9367] 0.1627 [0.0359; 0.3453]
 CP/Flu 17 0.7378 [0.5771; 0.8745] 0.1105 0.1028 [0.0387; 0.1858] 0.5905
CAR-T target
 BCMA 16 0.6973 [0.5124; 0.8576] 0.0836 [0.0405; 0.1646]
 BCMA + CD19/bispecific BCMA 6 0.8978 [0.8196; 0.9587] 0.0225 0.1641 [0.0380; 0.4935] 0.3979
Costimulatory domain
 4-1BB 20 0.7286 [0.5857; 0.8533] 0.0905 [0.0454; 0.1457]
 CD28 4 0.8946 [0.5848; 1.0000] 0.306 0.2311 [0.0000; 0.6907] 0.4317